ClinicalTrials.govpublic full text
Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection
sars-cov-2, severe acute respiratory syndrome coronavirus 2, covid-19, exosomes, ards, cd24, cd-24 exosomes, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800420
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.